FDA 50-State Conference Call

Event Date: 
Tuesday, June 22, 2021
Add to Calendar
Event Type: 
Non-NEHA Event

 

The Food and Drug Administration (FDA) will host a 50-State Conference Call on June 22, 2021, to discuss the new Retail Flexible Funding Model (RFFM). RFFM is a new funding opportunity for retail regulatory agencies at the state, local, territorial, or tribal level who are enrolled in the Voluntary National Retail Food Regulatory Program Standards (Retail Program Standards). Retail regulatory agencies not enrolled in the Retail Program Standards may also attend to gain an understanding of the funding opportunity should they wish to enroll.

The call will include information on the funding model itself, requirements for applying, estimated funding available, and timelines for the application process.

FDA 50-State Conference Call Information

Date: Tuesday, June 22, 2021

Time: 12–1 p.m. EDT

Audio*

Phone number: (800) 857-5383

*After you have typed in the phone number and numerical participant passcode above using your keypad, you will be asked by the automated voice capture system to verbally provide your name and organization slowly and clearly with spelling before being placed in the audio portion of the conference call. Please do not enter your name and organization using your phone keypad—you must verbally provide your name and organization (ensure that your mute button is off). After dialing in to the audio portion of the call, click on the WebEx link below to view the slides that will be displayed during the call.

Net Conference (To view slides, click on WebEX link below.)

Conference number: PWXQ2217126

Participant passcode: 6345265

WebEx Link:   

https://www.mymeetings.com/nc/join.php?i=PWXW2217126&p=6345265&t=c

Note. WebEx required download: To use Webex to view slides presented during the call, participants must have the Webex Event Manager installed prior to joining. To download the Event Manager, see instructions on the WebEx Downloads page.

 

Organization: 
Food and Drug Administration
Email: 
DivComm-ORA@fda.hhs.gov